Evaluation of effects of lignocaine infusion on postoperative pain relief for abdominal surgery.
Not Applicable
- Conditions
- Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhereHealth Condition 2: K566- Other and unspecified intestinal obstruction
- Registration Number
- CTRI/2020/04/024743
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients in age groups 18- 70
Healthy patients belonging to ASA PS I and II
Patients undergoing elective upper abdominal surgery.
Exclusion Criteria
Inability to understand preoperative instructions regarding use of PCA pump or pain score
Planned elective postoperative mechanical ventilation
Patients known to be on anti-arrhythmic drug therapy
History of COPD, cardiac, hepatic, renal or nervous system disorder
Known allergy to lignocaine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TIME INTERVAL between skin closure and first morphine PCA request. <br/ ><br>TOTAL MORPHINE CONSUMPTION at the end of 2nd, 6th, 12th, 24th and 36th postoperative hour. <br/ ><br>Timepoint: Immediate postoperative period <br/ ><br>36 hours after surgery <br/ ><br>
- Secondary Outcome Measures
Name Time Method PAIN SCORE (NRS) at rest, on deep inspiration, cough and movement (side to side or leg raising) at the end of 2nd, 6th, 12th, 24th and 36th postoperative hour. <br/ ><br>Any complaints of â??perioral numbness, light headedness. <br/ ><br>Sedation level <br/ ><br>Timepoint: Immediate postoperative period <br/ ><br>36 hours after surgery